KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Accounts Payables (2017 - 2025)

Guardant Health (GH) has disclosed Accounts Payables for 9 consecutive years, with $54.4 million as the latest value for Q4 2025.

  • Quarterly Accounts Payables rose 41.22% to $54.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.4 million through Dec 2025, up 41.22% year-over-year, with the annual reading at $54.4 million for FY2025, 41.22% up from the prior year.
  • Accounts Payables hit $54.4 million in Q4 2025 for Guardant Health, up from $20.1 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $205.3 million in Q3 2023 to a low of $15.5 million in Q3 2024.
  • Historically, Accounts Payables has averaged $69.5 million across 5 years, with a median of $41.7 million in 2022.
  • Biggest five-year swings in Accounts Payables: skyrocketed 1335.44% in 2021 and later tumbled 92.46% in 2024.
  • Year by year, Accounts Payables stood at $105.4 million in 2021, then surged by 66.87% to $175.8 million in 2022, then plummeted by 70.57% to $51.7 million in 2023, then decreased by 25.49% to $38.6 million in 2024, then soared by 41.22% to $54.4 million in 2025.
  • Business Quant data shows Accounts Payables for GH at $54.4 million in Q4 2025, $20.1 million in Q3 2025, and $44.8 million in Q2 2025.